Dissecting the impact of chimeric antigen receptor expression levels on T cell behaviour and response
Chimeric antigen receptor (CAR) T cells have heralded in a new age in cancer treatment. CAR T therapy has demonstrated remarkable responses in cancer patients of blood cancers. The therapy's success lies in the expression of a chimeric antigen receptor (CAR) that reprograms and redirects T cell...
Main Author: | Ramos, AS |
---|---|
Other Authors: | Fulga, T |
Format: | Thesis |
Language: | English |
Published: |
2022
|
Subjects: |
Similar Items
-
Effective chimeric antigen receptor T cells against SARS-CoV-2
by: Xueyang Guo, et al.
Published: (2021-11-01) -
Development of chimeric antigen receptor (CAR)-T cells targeting A56 viral protein implanted by oncolytic virus
by: Euna Cho, et al.
Published: (2024-03-01) -
Ex vivo pleural effusion cultures to study chimeric antigen receptor T cell cytotoxicity in an immunocompetent environment
by: Zachary E. Tano, et al.
Published: (2023-11-01) -
Multi-omics analysis and modelling of T cell immunity and interferon signalling pathways for engineered T cell therapy
by: Pavillet, CE
Published: (2022) -
Fine tuning gene expression levels in mammalian cells with engineered microRNA target sites
by: Michaels, Y
Published: (2018)